Fluvoxamine for the treatment of COVID-19 – Author's reply
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 2022
has subject area
- 0605 Microbiology (FoR)
- 1117 Public Health and Health Services (FoR)
- COVID-19 Drug Treatment (MeSH)
- Fluvoxamine (MeSH)
- Humans (MeSH)
- SARS-CoV-2 (MeSH)
published in
- The Lancet Global Health Journal